
MRK News
Merck & Co., Inc.
$132.72
-$5.06(-3.67%)
61
Overall
80
Value
41
Tech
63
Quality
Market Cap
$327.19B
Volume
11.18M
52W Range
$92.11 - $156.92
Target Price
$162.33
MRK news: the latest Merck & Co., Inc. headlines, press releases and market updates, newest first.
Latest MRK News
- Merck Appoints Douglas Baker Jr. as Lead DirectorTipRanks Auto-Generated Newsdesk · Nov 18, 2026
- Merck Appoints Douglas Baker Jr. as Lead DirectorTipRanks Auto-Generated Newsdesk · Nov 18, 2026
- Lock In the Consumer Staples Sector with This ETFTheStreet Pro · Nov 17, 2026
- Merck KGaA (0O14) Gets a Hold from BernsteinTipRanks Auto-Generated Intelligence Newsdesk · Nov 17, 2026
- 3 ETFs with Room for 10% or More Gains, According to AI AnalystSolomon Oladipupo · Nov 16, 2026
- Barclays Reaffirms Their Buy Rating on Newmark Group (NMRK)TipRanks Auto-Generated Intelligence Newsdesk · Nov 16, 2026
- Vivmark Residential Reports Updated Pro Forma Financial InformationTipRanks Auto-Generated Newsdesk · Nov 13, 2026
- Analysts Conflicted on These Healthcare Names: Lexeo Therapeutics, Inc. (LXEO), Merck & Company (MRK) and OptimizeRx (OPRX)TipRanks Newsroom · Nov 12, 2026
- UBS Keeps Their Hold Rating on Merck KGaA (0O14)TipRanks Auto-Generated Intelligence Newsdesk · Nov 12, 2026
- Market Wrap: Stocks Close Higher as AI Trade Is ReignitedJoel Baglole · Nov 11, 2026
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT) and Merck & Company (MRK)TipRanks Newsroom · Nov 10, 2026
- Vivmark Residential Earnings Call Signals Stronger Growth AheadTipRanks Auto-Generated Newsdesk · Nov 9, 2026
- Analysts Offer Insights on Real Estate Companies: Tanger (SKT), Vivmark Residential (VMRK) and Colliers International Group (CIGI)TipRanks Newsroom · Nov 5, 2026
- Vivmark Residential (VMRK) Receives a Buy from Morgan StanleyTipRanks Auto-Generated Intelligence Newsdesk · Nov 5, 2026
- Leerink Partners Sticks to Their Buy Rating for Merck & Company (MRK)TipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- Merck Stock (MRK) Rises 2% on $830 Million Keytruda Sales Beat Q3 Forecasts and Higher Full-Year Profit OutlookAnnika Masrani · Oct 29, 2026
- Barclays Keeps Their Buy Rating on Merck & Company (MRK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Merck & Company (MRK) Gets a Hold from Cantor FitzgeraldTipRanks Auto-Generated Intelligence Newsdesk · Oct 27, 2026
- Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Merck & Company (MRK) and Alnylam Pharma (ALNY)TipRanks Newsroom · Oct 27, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Oct 27, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRK | $132.72 | -3.7% | 11.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |